Carl Icahn

Carl Icahn

Last Update: 03-17-2017

Number of Stocks: 19
Number of New Stocks: 0

Total Value: $22,374 Mil
Q/Q Turnover: 3%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

Carl Icahn Watch

  • The Most Attractive Value Stock There Is?

    Of all the data contained in hedge fund 13F filings published over the past few weeks for trading activity conducted during the last quarter of 2016, there is one trend that really stands out.


    In the value-oriented hedge funds sector, there seems to be one stock all value investors love, and they are all in the position in a big way. Such a large number of value hedge fund managers chasing the same company in a concentrated way leads me to believe it actually is undervalued.

      


  • Carl Icahn Willing to Pay More for Herbalife

    Carl Icahn (Trades, Portfolio) has signaled increasing confidence in his bet on Herbalife (NYSE:HLF), paying more per share this week to add to his position than he has on average for previous purchases, as odds mount against the short thesis on the company by fellow investor Bill Ackman (Trades, Portfolio).

    Icahn bought 372,324 shares of the multilevel marketing company on March 10, according to GuruFocus data on March 13 filings. The buy increases his position in the company by 1.65% to 22,872,324 shares, or a 24.57% stake.  


  • 5 Traits You Need to Be a Successful Value Investor

    Value investing is often touted as the best investment style to follow if you want to outperform over the long term. The world’s most renowned investors such as Warren Buffett (Trades, Portfolio), Carl Icahn (Trades, Portfolio) and others have accumulated massive fortunes by buying undervalued equities and riding them to profit.


    Value investing is not as easy as buying the cheapest stocks on the market and waiting. Along with the financial expertise needed to pick the best value investments, you also need to have a firm conviction in your own picks. Here are the five key traits you need to be a successful value investor.

      


  • AIG: Time To Buy?

    While the rest of the market has rallied during the first few months of this year, shares in American International Group (NYSE:AIG) have struggled thanks to a large, unexpected reported loss for the fourth quarter of 2016.


    For the fourth quarter, the company reported a $3 billion loss, thanks to $5.6 billion of loss provisions. Claims on commercial insurance contracts have continued to be much bigger than anticipated when the policies were written. In other words, American International Group is still trying to make up for its past mistakes nearly a decade after its financial crisis bailout of $185 billion. The company has divested 17 businesses were a total of $13 billion as part of a two-year turnaround plan, which began a year ago.

      


  • Why You Really Need to Diversify

    Diversification, and the benefits thereof, is something I have written about multiple times before. Recently, however, I have discovered two pieces of data that really highlight how important diversification is to a well-rounded investment strategy. The numbers are enough to terrify even the most devoted, concentrated investor.


    Time to diversify?

      


  • The Key to Successful Investing Is Understanding Your Weaknesses

    I have something to tell you. You are not Warren Buffett (TradesPortfolio). No matter how carefully you follow his trades, how often you read his advice or how much of a Buffett scholar you think you are, you are not the "Oracle of Omaha." You are not even close.


    This is a bit of a generalization. What I am trying to say is that no matter how much research you do into a particular investor or investing style, you are not an expert on the topic. And you certainly should not invest unless you understand this caveat.

      


  • New Feature Announcement: The User Manuals

    As we ring in March 2017, we are pleased to announce a new feature on GuruFocus, the User Manuals. Like cooking recipes, these user manuals give detailed instructions on how to use our most popular features on the website.


    Throughout the past few years, GuruFocus introduced several new features for our Premium and Premium Plus members, including customized series in Interactive Charts, custom filters and screeners, backtesting, the DCF Fair Value Calculator, personalized guru lists, the All-in-one Guru Screener and backtesting, My Portfolios, GuruFocus in Excel and the Application Programming Interface (API). This article will briefly discuss each of the above features and give links to the respective user manuals.

      


  • Bill Ackman Expands Chipotle Position, Cuts Zoetis

    Activist investor Bill Ackman (Trades, Portfolio), founder of Pershing Square Capital Management, buys the common stock of companies and pushes for changes so that the market can realize the values of these companies. Like fellow activist investor Carl Icahn (Trades, Portfolio), Ackman buys out-of-favor companies at a discount and sells them when the companies reach their appraised value.


    During fourth-quarter 2016, Ackman purchased additional shares in Chipotle Mexican Grill Inc. (NYSE:CMG) and eliminated his stake in Zoetis Inc. (NYSE:ZTS). The investor also trimmed his position in three companies: Valeant Pharmaceuticals International Inc. (NYSE:VRX), Platform Specialty Products Corp. (NYSE:PAH) and Air Products & Chemicals Inc. (NYSE:APD).

      


  • Carl Icahn Expands Industrial Empire

    Activist investor Carl Icahn (Trades, Portfolio) departs from consensus thinking, investing in out-of-favor companies and pushing for changes. The Icahn Management LP fund manager expanded his positions in four companies recently: Federal-Mogul Holdings Corp. (NASDAQ:FDML), Hertz Global Holdings Inc. (NYSE:HTZ), Icahn Enterprises LP (NASDAQ:IEP) and Herbalife Ltd. (NYSE:HLF). Icahn has been buying shares in these four companies in the past quarters.


    Federal-Mogul Holdings

      


  • A Mid-Cap Growth Stock With No Debt

    The All-In-One screener at GuruFocus continues to pull up interesting candidates for review; this time it is Dorman Products Inc. (NASDAQ:DORM), a result of (again) asking the screener for companies that have 5-Star Predictability ratings and no debt.


    Previously, I profiled three other companies with these two characteristics: Rollins Inc. (NYSE:ROL), Jack Henry & Associates Inc. (NASDAQ:JKHY) and NICE Systems Ltd. (NASDAQ:NICE).
      



  • How to Build a Peter Lynch-Style Growth Strategy

    Next to investment legends such as Warren Buffett (Trades, Portfolio) and Carl Icahn (Trades, Portfolio), Peter Lynch falls by the wayside, but his influence on the investment world has inspired more change than possibly Buffett and Icahn put together.


    Lynch is considered to be the greatest mutual fund manager of all time. The fund he managed, Fidelity Investment's Magellan Fund, produced an average annual return of 29.2% from 1977 until 1990, almost doubling the Standard & Poor's 500’s annual yearly return of 15.8%. During this period, Lynch pioneered the growth-at-a-reasonable-price style of investing. Lynch believed that the faster a company was growing, the more investors should be willing to pay for it, which makes a lot of sense today, but before Lynch’s success, the market tended to overlook growth and value together.

      


  • Back to the Future

    Conduent (NYSE:CNDT) span off from Xerox (NYSE:XRX) on Jan. 3. It was the business process outsourcing (BPO) business within the services segment of Xerox. It has $6.6 billion revenue, $630 million EBITDA and 94,000 employees in a market growing at 5% to 6% a year. According to Xerox, its BPO business, or Conduent, has No. 2 market share. This is confirmed by the leading IT research and advisory firm Gartner Inc.


      


  • Carl Icahn Discloses 10 Percent Stake in Xerox Spinoff Conduent

    Carl Icahn (Trades, Portfolio), an investor known for effecting change at companies he invests in, today reported the product of his recent division of hardware company Xerox (NYSE:XRX) – a haul of 19,806,00 shares of the new services company, Conduent (NYSE:CNDT).


    Icahn had begun amassing his stake totaling 99,030,026 shares of Xerox in the fourth quarter of 2015. By Nov. 8, the company announced its decision to divide into two entities and issue to shareholders one share of Conduent for every five shares of Xerox. Icahn received his stake in Conduent, which is one-fifth of his stake in Xerox, in the distribution and effectively owns 9.77% of the new company.

      


  • Gurus and Insiders Invest in Industrial and Medical Companies

    Among U.S. companies, industrial and medical companies have high guru and insider buys during 2016. Such companies include Hertz Global Holdings Inc. (NYSE:HTZ), Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) and Myriad Genetics Inc. (NASDAQ:MYGN). These double buys have good value potential in early 2017.


    What is a double buy?

      


  • The Danger on Which Gurus Agree

    Intrinsically ETFs are a tremendous innovation and a great positive. Unfortunately at this stage if you want to raise a lot of money as an asset manager you need to play into fear and greed. Customers want more, and they don’t want to lose. Ever.


    ETFs get investors more. They are much cheaper to run compared to an actively managed fund. With active managers, in the aggregate, failing to deliver returns in excess of their expenses ETFs win out. So far, so good.

      


  • Buy Refiners After Carl Icahn's Appointment

    Carl Icahn (Trades, Portfolio) has long been a vocal critic of the substantial regulatory burden placed on businesses by the U.S. government, and it now looks as if this jawboning has paid off. President-elect Donald Trump appointed him special adviser on regulatory reform Wednesday.


    It is unclear which sectors will benefit the most from Icahn’s appointment, but one industry that stands to benefit more than most is refiners.

      


  • Technology Companies Among Strong Guru Ownership Stocks

    While all investment gurus seek long-term capital appreciation, not all gurus think identically. Some gurus invest in companies with a fundamental, value-oriented approach while other gurus, like Bill Ackman (Trades, Portfolio) and Carl Icahn (Trades, Portfolio), actively invest in distressed companies and generate value through company reforms. However, regardless of their investing approach, gurus usually invest in companies that offer high value potential to their fund and shareholders.


    In Part 1, we analyzed the Aggregated Portfolio of Gurus, which lists the 50 companies with the highest combined weighting among the gurus selected through the “Personalized List” feature.

      


  • Gurus Shop in Robust Consumer Cyclical and Technology Sectors

    During the third quarter, gurus invested primarily in consumer cyclical and technology companies. Such companies have strong financial strength and high profitability. Several of these companies, including Alphabet Inc. (GOOG) (NASDAQ:GOOGL), Apple Inc. (NASDAQ:AAPL), Alibaba Group Holding Ltd. (NYSE:BABA), The Priceline Group Inc. (NASDAQ:PCLN), Amazon.com Inc. (NASDAQ:AMZN) and The Walt Disney Co. (NYSE:DIS), have a predictability rank of at least three stars. High guru ownership and number of guru buys suggest good value potential in the consumer cyclical and technology sectors.


    Tracking “favorite” gurus with Personalized Guru Lists

      


  • Is Icahn Enterprises Better Than Berkshire?

    Of all the world’s great investors, Carl Icahn (Trades, Portfolio) is perhaps the most feared and respected at the same time. Icahn started his life on Wall Street as a stockbroker and worked his is way up to become the Street’s most respected activist investor and most feared corporate raider.


    From 1968 through 2011, Icahn compounded the initial $100,000 he invested in his Wall Street firm at a 31% annual rate. Over the same period, the book value of Warren Buffett (Trades, Portfolio)’s Berkshire Hathaway (NYSE:BRK.A)(NYSE:BRK.B) grew only 20% annualized.

      


  • Carl Icahn Takes 15% Stake in Enzon Pharmaceuticals

    After selling out in the second quarter, Carl Icahn (Trades, Portfolio) acquired an even larger position in Enzon Pharmaceuticals (ENZN) on Nov. 28.


    He bought 6,598,886 shares for an average cost of 41 cents per share. This represents nearly 15% of the company’s outstanding shares but only accounts for 0.01% of his total assets managed.

      


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)